Page 1

Interim Report 2 ( 2021-08-01 - 2021-10-31 ) Phase Holographic Imaging PHI AB ( publ ) Lund , December 29 , 2021 Cell therapy manufacturing AUGUST 2021 - OCTOBER 2021 Net sales Operating result before depreciation ( EBITDA ) Net result Earnings per share Gross margin 1 818 ( 826 ) KSEK -2 733 ( -2 946 ) KSEK -3 901 ( -4 777 ) KSEK -0.27 ( -0.33 ) SEK 93 ( 77 ) % MAY 2021 - OCTOBER 2021 Net sales Operating result before depreciation ( EBITDA ) Net result Earnings per share Gross margin 4 191 ( 957 ) KSEK -6 172 ( -7 495 ) KSEK -8 370 ( -11 194 ) KSEK -0.58 ( -0.78 ) SEK 75 ( 64 ) % IN SHORT Strong sales growth for the 3rd consecutive quarter . • The HoloMonitor fluorescence unit is planned to be launched in the first half of 2022 . • Recent advancements in regenerative medicine create additional growth potential in clinical applications for the company .